Amgen

These 5 Firms Could Buy Celgene's Otezla Ahead Of The Bristol Merger
Investors Business Daily
Fri, 07/19/19 - 10:44 am
Bristol-Myers Squibb
Celgene
M&A
Otezla
Gilead Sciences
Amgen
Regeneron
Eli Lilly
JNJ
Emgality-maker Lilly courts payers with new migraine ER data
Fierce Pharma
Fri, 07/12/19 - 12:22 pm
Eli Lilly
Emgality
cluster headache
migraines
Amgen
Novartis
Teva Pharmaceutical
ER
Amgen, Novartis BACE Inhibitor Joins List of Failed Alzheimer’s Drugs
Xconomy
Thu, 07/11/19 - 11:15 pm
Alzheimer's disease
BACE inhibitors
Merck
Eli Lilly
AstraZeneca
Amgen
Novartis
Biogen Eisai
German court blocks sale of Sanofi, Regeneron cholesterol drug
Biopharma Dive
Thu, 07/11/19 - 05:25 pm
patents
Amgen
Sanofi
Regeneron
Germany
Praluent
Repatha
Amgen/UCB hit another Evenity hurdle, as European regulators fail to back the osteoporosis drug
Endpoints
Fri, 06/28/19 - 10:04 am
Amgen
UCB Pharma
FDA
EMA
Europe
osteoporosis
Evenity
romosozumab
3 Big Drugmakers Most Likely to Make Acquisitions After Pfizer's Surprise Deal
Motley Fool
Tue, 06/18/19 - 11:54 am
Pfizer
Array Biopharma
M&A
Amgen
Gilead Sciences
Biogen
Amgen, Lilly, Merck sue HHS to block price disclosures in DTC ads
BioCentury
Fri, 06/14/19 - 06:26 pm
HHS
DTC ads
television ads
Merck
Eli Lilly
Amgen
FDA Approves 20th Biosimilar, 5th for Roche’s Herceptin
RAPS.org
Thu, 06/13/19 - 10:37 pm
FDA
biosimilars
Roche
Herceptin
Amgen
Kanjinti
Will The Introduction Of A Third Potent Cholesterol Lowering Drug Expand or Shrink The Market?
Forbes
Mon, 06/10/19 - 10:31 am
The Medicines Company
Amgen
Sanofi
Regeneron
inclisiran
PCSK9 inhibitors
3 takeaways from cancer's biggest conference
Biopharma Dive
Thu, 06/6/19 - 10:03 pm
Amgen
KRAS
accelerated approvals
Turning Point Therapeutics
Keytruda
Opdivo
ASCO 2019
ASCO 2019: The Long Game, Targeted Pills, First-Ever Buzz & More
Xconomy
Wed, 06/5/19 - 10:43 am
ASCO 2019
cancer
immunotherapy
diagnostics
Veracyte
Grail
Moderna Therapeutics
Amgen
Nektar Therapeutics
Blueprint Medicines
Merck
AstraZeneca
Roche
breast cancer
Amgen Cancer Treatment Candidate Had 'Adverse Events' in Almost Half of Patients
TheStreet.com
Wed, 06/5/19 - 09:35 am
Amgen
AMG 420
Multiple Myeloma
3 Cancer Stocks Given a Lift by Amgen
Motley Fool
Tue, 06/4/19 - 11:07 am
Amgen
KRAS
AMG 510
Mirati Therapeutics
Array Biopharma
Gilead Sciences
ASCO 2019
Did This Biotech Giant Just Find The Key To An 'Undruggable' Protein?
Investors Business Daily
Mon, 06/3/19 - 11:37 pm
Amgen
AMG 510
KRAS
ASCO 2019
lung cancer
colon cancer
Early cancer drug data give Amgen hope it's 'cracked KRAS code'
Biopharma Dive
Mon, 06/3/19 - 11:30 am
ASCO 2019
KRAS
lung cancer
colorectal cancer
pancreatic cancer
Amgen
AMG 510
3 Charts Every Amgen Investor Needs to See
Motley Fool
Sun, 05/26/19 - 11:14 am
Amgen
Mass exodus of Amgen sales reps sparks legal battle with multiple myeloma rival Karyopharm
Fierce Pharma
Fri, 05/24/19 - 04:35 pm
Amgen
sales poaching
drug reps
Karyopharm Therapeutics
Multiple Myeloma
Selinexor
Amgen offers $167m for drug discovery biotech Nuevolution
Pharmaforum
Wed, 05/22/19 - 10:52 am
Amgen
Nuevolution
R&D
M&A
Here's Why Mirati Therapeutics Is Surging Today
Motley Fool
Thu, 05/16/19 - 06:42 pm
Mirati Therapeutics
Amgen
KRAS inhibitors
MRTX849
AMG 510
May 15 ASCO Quick Takes: After-hours pop for Iovance, MacroGenics; plus Takeda, Amgen, Forty Seven
BioCentury
Wed, 05/15/19 - 11:52 pm
Iovance
LN-145
cervical cancer
Takeda
TAK-788
non-small cell lung cancer
Amgen
AMG-510
Macrogenics
margetuximab
HER2-positive metastatic breast cancer
Forty Seven

Pages